Last edition
News about
MSN Laboratories Launches Affordable JAK Inhibitors to Boost Access for Indian Patients
The launch of JAK inhibitors enhances the accessibility and affordability of advanced treatments for patients suffering from various autoimmune diseases, including Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis, Crohn's Disease and Atopic Dermatitis. Both molecules are also approved by the US FDA.
Cadila Pharmaceuticals Introduces Dlorfast-M Tablets to Treat Allergic Rhinitis and Urticaria
Allergic rhinitis and urticaria are chronic health conditions that affect millions of people globally. Cadila Pharmaceuticals has introduced Dlorfast-M as a dual-action therapy targeting two pathways of the allergic response—histamine and leukotriene—aiming to provide wider and more effective symptom management.
Cumberland Pharmaceuticals Expands Vibativ Access Through Premier Group Purchasing Agreement
American specialty pharmaceutical company Cumberland Pharmaceuticals has announced that its potent antibiotic Vibativ (telavancin) has been added to a national group purchasing agreement with Premier, a leading US healthcare improvement company.
Johnson & Johnson MedTech Launches INHANCE INTACT System for Muscle-Sparing Shoulder Replacement
Johnson & Johnson MedTech will showcase its INHANCE INTACT System at the American Shoulder and Elbow Surgeons (ASES) Annual Meeting, taking place October 15–18, 2025, in San Diego, California.
EG BioMed Earns CAP Accreditation, Boosting YD Bio's Cancer Diagnostics
EG BioMed is one of YD Bio’s key licensing partners for pancreatic and breast cancer detection and collaborates with 3D Global to develop treatments for eye disorders.
Hikal Opens New High Potency API Lab in Pune
Hikal Ltd., a preferred long-term partner to leading global life sciences companies, has inaugurated its state-of-the-art High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory at the company’s Integrated Innovation Centre in Pune.
NextPharma to Sell Healthcare Logistics Business to Cencora
European pharmaceutical contract development and manufacturing organisation (CDMO) NextPharma has signed an agreement with Cencora, a US-based pharmaceutical solutions company, to sell its healthcare logistics services arm, NextPharma Logistics GmbH.
AskBio Reports Safety Data from AB-1003 LGMD 2I/R9 Study
Data from first cohort of five participants suggest an acceptable safety profile for AB-1003 in participants with Limb-Girdle Muscular Dystrophy (LGMD) 2I/R9, with no dose-limiting toxicities or serious adverse events reported up to 52 weeks post-treatment.
Lupin to Present Phase 1 Data on LNP3693 (STING agonist) at ESMO Congress 2025
Lupin will present data from its Phase 1a clinical trial evaluating LNP3693, a STING agonist, at the ESMO Congress in Berlin, Germany, scheduled to be held from October 17 to October 21, 2025.
Motorica Introduces Digital Prosthetics to India
Russian MedTech company Motorica has officially launched its Digital Prosthetics Programme in India, marking a significant step toward transforming the production and accessibility of prosthetic solutions in the country.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy